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Abstract
The Fell and Dales are rare native UK pony breeds at risk due to falling numbers, in-breeding, and inherited disease.
Specifically, the lethal Mendelian recessive disease Foal Immunodeficiency Syndrome (FIS), which manifests as B-lymphocyte
immunodeficiency and progressive anemia, is a substantial threat. A significant percentage (,10%) of the Fell ponies born
each year dies from FIS, compromising the long-term survival of this breed. Moreover, the likely spread of FIS into other
breeds is of major concern. Indeed, FIS was identified in the Dales pony, a related breed, during the course of this work.
Using a stepwise approach comprising linkage and homozygosity mapping followed by haplotype analysis, we mapped the
mutation using 14 FIS–affected, 17 obligate carriers, and 10 adults of unknown carrier status to a ,1 Mb region (29.8 –
30.8 Mb) on chromosome (ECA) 26. A subsequent genome-wide association study identified two SNPs on ECA26 that
showed genome-wide significance after Bonferroni correction for multiple testing: BIEC2-692674 at 29.804 Mb and BIEC2-
693138 at 32.19 Mb. The associated region spanned 2.6 Mb from ,29.6 Mb to 32.2 Mb on ECA26. Re-sequencing of this
region identified a mutation in the sodium/myo-inositol cotransporter gene (SLC5A3); this causes a P446L substitution in the
protein. This gene plays a crucial role in the regulatory response to osmotic stress that is essential in many tissues including
lymphoid tissues and during early embryonic development. We propose that the amino acid substitution we identify here
alters the function of SLC5A3, leading to erythropoiesis failure and compromise of the immune system. FIS is of significant
biological interest as it is unique and is caused by a gene not previously associated with a mammalian disease. Having
identified the associated gene, we are now able to eradicate FIS from equine populations by informed selective breeding.
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Introduction
The Fell and Dales are related sturdy pony breeds traditionally
used as pack animals to carry goods over the difficult upland terrain
of northern England. Both breeds experienced near extinction
during WWII, and the current populations aredescended from very
few animals. It is likely that this genetic bottleneck, together withthe
use of prominent sires, was responsible for the emergence of a fatal
Mendelian recessive disease, FIS, which currently affects up to 10%
of Fell and 1%of Dales foals (data from UK breed societies). Both of
these breeds are registered with the Rare Breeds Survival Trust due
to their falling numbers, and important position in the UK’s
agricultural heritage.
FIS was first described in 1998 as a unique syndrome in which
affected Fell foals develop diarrhoea, cough and fail to suckle [1].
Despite an initial response to treatment, the infections persist and
were shown to be due to a primary B-cell deficiency [2] associated
with reduced antibody production, with tested immunoglobulin
isotypes including IgM, IgGa, IgGb and IgG(T) being significantly
reduced [3]. Paradoxically, circulating T-lymphocyte numbers are
normal [4]. The reduced antibody levels in affected foals are
consistent with an inability to generate an adaptive immune
response, resulting in immunodeficiency once colostrum-derived
immunoglobulin levels decrease at 3–6 weeks of age. This loss of
maternally derived antibodies correlates with typical onset of FIS
signs at 4–6 weeks. Concurrently, affected foals develop a non-
hemolytic, non-regenerative progressive profound anemia [5], in
itself severe enough to cause death and the main marker for
euthanasia decisions by vets.
As a result of FIS, foals die or are humanely destroyed between
1–3 months of age, the disease being 100% fatal. In 2009, this
condition was reported in the Dales breed [6]; it is likely that the
mutation has passed between the breeds given the similarity
between them and the practice of occasional interbreeding. The
clinical and pathological findings for FIS are compatible with a
primary defect of genetic origin [1], and this is supported by
extensive genealogical studies [6,7]. FIS has a pattern of
inheritance typical of an autosomal recessive disease, and the
likely founder animal, which features in both the Fell and Dales
studbooks, has been traced by pedigree analysis.
PLoS Genetics | www.plosgenetics.org 1 July 2011 | Volume 7 | Issue 7 | e1002133Primary immunodeficiences, which include depleted levels of
lymphocytes and/or immunoglobulins, have previously been
reported in the horse. The recessive defect ‘severe combined
immunodeficiency’ (SCID), which is found in the Arabian breed,
comprises a fatal deficiency in T- and B-lymphocyte numbers and
function. The underlying lesion was found to be a 5 base-pair
deletion in the gene coding DNA-dependent kinase, catalytic
subunit DNA-PKCS [8], a protein involved in V(D)J recombination
required for adaptive immunity [9]. Like FIS foals, SCID foals have
a markedly reduced thymus and have reduced numbers of germinal
centers in secondary lymphoid organs [10]; unlike SCID foals
however, FIS foals have apparently normal numbers of circulating
T-cells [4]. Primary aggamaglobinemia is rare in horses and
comprises of a complete absence of immunoglobulin and reduced
peripheral B-lymphocyte levels, with normal T-lymphocyte activity
[11]. In this respect there is a similarity to FIS, however primary
aggamaglobinemia is only observed in males and is X-linked.
Furthermore, profound anemia in combination with B-lymphope-
nia has not previously been reported in the horse or any other
species, and as such FIS appears to be a unique disease process.
Here we report the mapping and identification of the genetic
lesion that causes FIS. An initial scan using microsatellite markers
identified the chromosome region responsible. The opportune
production of a SNP chip, which utilized the SNP variants
generated during the sequencing of the equine genome (http://
www.broadinstitute.org/mammals/horse) then allowed a confir-
matory association scan. This was followed by re-sequencing of the
implicated region in order to identify the causal mutation.
Results
Microsatellite Analysis
A genome-wide microsatellite scan was performed on 41
individuals taken from five pedigrees of Fell ponies in which FIS
was segregating (Figure S1), using a panel of 228 markers (Table S1).
The data were examined both for loss of heterozygosity and for
linkage (Table S2). Only one microsatellite, at 30.25 Mb on ECA26,
showed a significant loss of heterozygosity (x
2=7.15,P=0.028)and
significant linkage (LOD score =3.29 at h=0) to the disease.
SNP Association Scan
The location of the lesion was confirmed and refined using a
genome-wide association analysis with an equine SNP array
(Illumina EquineSNP50 Infinium BeadChip), which contains
54,602 validated SNPs. After applying quality control (see
Materials and Methods), data were available for 42,536 SNPs in
49 individuals (18 FIS-affected and 31 controls). To consider
whether there was any population stratification among the
samples, a multi-dimensional scaling plot of the genome-wide
identity-by-state distances was performed (Figure S2); there was no
significant difference between the affected and control samples for
the first two components (P=0.553). In addition, a quantile-
quantile plot (Figure S3) to compare the expected and observed
distributions of –log10(P), obtained by a basic association test,
showed that there was little evidence of inflation of the test
statistics (genomic inflation factor l=1.04), indeed the test
statistics appear to be marginally depressed rather than inflated.
No correction was considered necessary. Two SNPs on ECA26
showed genome-wide significance after Bonferroni correction for
multiple testing (Figure 1A). These are BIEC2-692674 at
29.804 Mb (Praw=2.88610
27) and BIEC2-693138 at 32.19 Mb
(Praw=1.08610
26). The associated region spanned 2.6 Mb from
position 29.6 Mb to 32.2 Mb on ECA26 (Figure 1B).
In a subsequent fine-mapping phase, 62 additional SNPs within
the region were genotyped on 13 FIS-affected samples. Several
novel SNPs were identified (dbSNP ss295469621-295469629). In
addition, two further microsatellites were also genotyped (Table
S1). The homozygous affected haplotype was shared by these
animals over a 992 kb segment (Figure 2A). According to
ENSEMBL gene prediction, fourteen genes lie in this interval
(Figure 2B).
Resequencing of Critical Region
Five selected individual animals were re-sequenced over this
critical region using sequence capture by NimbleGen arrays
followed by GS FLX Titanium sequencing (GenBank submission
under study accession no. ERP000492). The five individuals
comprised one affected foal (A13 on Figure 2), the two obligate
carrier parents, one apparently clear animal and one obligate
carrier chosen for maximal homozygosity across the region. The
FIS carrier status and familial relationships were confirmed for
each individual by parentage verification. The last animal proved
particularly useful in eliminating many potential causal variants. In
total, eight verified SNPs were identified in the affected foal,
narrowing the critical region to 375,063 bp (ECA26: 30,372,557 –
30,747,620 bp). Coverage of this critical interval was increased
from 92.9% to 98.4% using Sanger sequencing; none of the
remaining gaps fell within 200 bp of protein-coding sequence.
Only one variant, a SNP at 30,660,224 bp, segregated as expected
for a causal recessive mutation within the five sequenced samples.
In addition there was no evidence of DNA rearrangement,
duplication or insertion/deletion seen in the affected foal (Figure
S4). The segregating SNP was assessed for validity as an FIS
marker in equine populations.
Population Screen
Subsequently all 38 available affected foals (37 Fell, 1 Dales)
were shown to be homozygous for the affected allele and all 21
available obligate carriers were heterozygous. A selection of Fell
and Dales samples which were submitted to the Animal Health
Trust for parentage verification between 2000 and 2010 were
anonymously screened for the affected allele: 82 / 214 (38%) of the
Fells and 16 / 87 (18%) of the Dales were heterozygous for the
lesion and no homozygous affecteds were discovered. These
carrier rates are consistent with the approximate observed disease
prevalence of 10% in the Fell and 1% in the Dales populations. In
addition, a selection of horse breeds (184 individuals from 11
breeds consisting of Thoroughbred (n=29), Appaloosa (n=8),
Author Summary
Foal Immunodeficiency Syndrome (FIS) is a genetic disease
that affects two related British pony breeds, namely the Fell
andthe Dales. Foalswith FISappearto be normalat birthbut
within a few weeks develop evidence of infection such as
diarrhoea, pneumonia, etc. The infections are resistant to
treatment, and the foals die or are euthanized before three
months of age. The foals also suffer from a severe progressive
anemia. Being a recessive condition, the disease is difficult to
control without a diagnostic DNA test to identify symptom-
free carrier parents. Within the last few years the horse
genome has been sequenced, and this has allowed the
development of tools to identify genetic mutations in the
horse at high resolution. In this article we demonstrate the
use of these new tools to identify the location of the FIS
mutation. The presumptive causal lesion was then identified
by sequencing this region. This has enabled us to develop a
test that can be used to identify carrier ponies, allowing
breeders to avoid FIS in their foal crop.
Identifying the Mutation in FIS
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(n=2), Cleveland Bay (n=20), Dartmoor Pony (n=19), Icelandic
Horse (n=8), New Forest Pony (n=20), Sheltand Pony (n=20)
and Shire (n=20)) which were considered unlikely to have
interbred with either the Fell or Dales was genotyped and all
proved homozygous wild-type.
Discussion
The identification of a mutation that segregates 100% with the
disease has enabled a diagnostic test to be developed and offered to
breeders and owners, allowing them to avoid carrier-carrier
matings, and consequently drastically reduce the numbers of FIS-
affected foals born each year. A gradual reduction in the use of
carrier animals will, over time, lead to a reduction in the affected
allele frequency in the population, while conserving the gene pool
as much as possible. In addition, other equine breeds that may
have interbred with the Fell or Dales will now be screened for FIS
carriers.
The FIS-associated SNP falls within the single exon of the
sodium/myo-inositol co-transporter gene (SLC5A3, also known as
SMIT), which is a cell membrane transporter protein responsible
for the co-transport of sodium ions and myo-inositol. This SNP is
non-synonymous, causing a P446L substitution in SLC5A3; this
amino acid residue (equivalent residue 451 in the human protein)
is conserved in all 11 placental mammals for which high-coverage
sequence is now available (selection shown in Figure 3). Similarly,
this residue is conserved in other solute carrier family 5 (SLC5)
paralogs in the horse which share similar structural homology
(Figure 3).
The crystal structure of a bacterial homolog of SLC5A1
(sodium/glucose co-transporter 1) has recently been elucidated
[12] and shows this member of the SLC5 family to have 14
transmembrane helices; the structural conformations adopted
during transport, and the precise positions of substrate binding
during transfer are now being identified [13]. Alignment of the
protein sequences of the SLC5 family suggests that P446 in equine
SLC5A3 is located in a transmembrane helix which is involved in
Figure 1. Identification of locus responsible for FIS by genome-wide association scan. (A) Manhattan plot of association test results
showing the chromosome locations of the 42,536 SNPs which passed quality control against –log10(P). The red line indicates the threshold for
genome-wide significance after Bonferroni correction for multiple testing (Praw=1.2610
26), which corresponds to an alpha value of 0.05. (B) Focus on
region of ECA26 that shows FIS association. The vertical broken lines indicate the region (29.6–32.2 Mb) which was investigated further by fine-
mapping.
doi:10.1371/journal.pgen.1002133.g001
Identifying the Mutation in FIS
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transfer. The two prolines at positions 445 and 446 may be
required for effective substrate binding by closing the substrate
binding site after the substrate is bound. Proline residues introduce
structural destabilisation into alpha helices and have long been
obvious candidates for points of conformational change required
for substrate binding and release [14]. Indeed, replacement of
prolines in the transmembrane helices of transport proteins has
shown that some residues are profoundly important in transport,
affecting either substrate affinity or substrate movement [15].
SLC5A3 is an osmotic stress response gene, which acts to prevent
dehydration caused by increased osmotic pressure in the
extracellular environment. Dehydration causes the disruption of
numerous cellular functions by denaturation of intracellular
molecules and damage to sub-cellular architecture [16]. Extreme
osmotic conditions are found in the kidney, although osmotic
Figure 2. SNP haplotypes and genes from the region of ECA26 genetically linked and associated with FIS. (A) The affected SNP
haplotype is shown on the left. The affected alleles for three key microsatellite markers are also included. The extent of conserved affected haplotypes
present in the 13 affected individuals (A1–13) are indicated with blue bars. Accession numbers (newly identified SNPs) or the local SNP ID number
(http://www.broadinstitute.org/ftp/distribution/horse_snp_release/v2/), together with the genome position are given. The minimal 992 kb shared
region of homozygosity (29,825 – 30,817 kb) is out-lined in orange. (B) The positions of the 14 ENSEMBL annotated genes within the conserved block
are indicated.
doi:10.1371/journal.pgen.1002133.g002
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and in particular are critical for lymphocyte development and
function [17,18].
The mechanism by which the osmotic stress response is mediated
in mammals is not completely understood, but involves a signaling
cascade comprising Rho-type small G-proteins, p38 Mitogen-
activated protein kinase (p38MAPK) and the transcription factor,
Nuclear Factor of Activated T-cells 5 (NFAT5) [19]. NFAT5 directly
stimulates the transcription of hyperosmolarity-responsive genes, of
which SLC5A3 is one. These act to counterbalance the effects of
extracellular osmotic pressure by transporting small organic
osmolytes, such as myo-inositol, into the cell, thereby maintaining
isotonicity with respect to extra-cellular conditions [20]. NFAT5 is
the only known transcriptional activator of hyperosmolarity response
genes, and was shown to be essential for normal lymphocyte
proliferation and adaptive immunity [18]. Targeted knockout of
NFAT5 in mice results in late gestational lethality whereas partial loss
of function leads to defects in adaptive immunity and a substantially
reduced spleen and thymus [18]. Furthermore, transgenic studies
identify loss of T-cell mediated immunity as the prime deficiency
ensuing from aberrant NFAT5 activity [21,22]. Similarly FIS-
affected foals have markedly reduced thymus and spleen with a lack
of germinal centers [1,23]. However, FIS disease immunopathology
indicates that FIS foals have apparently normal circulating T-cell
numbers with only peripheral blood B-lymphocyte numbers
significantlydepleted; currently, there are no data availableindicating
NFAT5 activity in specific B-lymphocyte functions.
Studies are now required to demonstrate the functional
differences between the Pro446 and Leu446 forms of the protein.
This will be achieved by introducing this mutation into transgenic
mice and assessing transport function. Further investigation into
the physiological consequences of this mutation will then also be
possible. In particular, it will be important to identify how the
mutation leads to profound anemia and B-lymphopenia whilst
neutrophils and T-cell numbers (including CD4/CD8 ratio) and
function (responses to mitogens PHA and Con A) appear normal
[4]. Importantly, it must be investigated whether there is a defect
in T-cell function that is currently undetected or whether the
antigen presenting function of B-cells is so suppressed that the T-
cells cannot respond. In addition, it must be noted that the
lymphoid organs in FIS foals have depleted thymus tissue and
poor germinal centre development in spleen and lymph nodes,
which suggests that there may be some unidentified T-cell
dysfunction. Alternatively, any T-cell defects could be due to
severe inflammatory responses in these very sick foals.
SLC5A3 is not associated with any described mammalian
disease, although a role in the pathogenicity of Down Syndrome is
suggested [24]. The effect of loss of SLC5A3 activity has not been
comprehensively studied, however SLC5A3 knockout mice die
shortly after birth due to hypoventilation [25], probably due to
failure of the peripheral nervous system [26]; similarly FIS-affected
foals have peripheral ganglionopathy [1].
There is relatively little literature on SLC5A3 function in
hemopoietic or immunological tissues, in any species, although a
Figure 3. SLC5A3 amino acid sequences alignments in the region of the FIS mutation. The amino acid affected by the mutation, indicated
with an arrow, is conserved in all placental mammals now sequenced with high coverage (n=11); the top panel shows alignments of this gene region
in a selection of these mammals. The bottom panel shows alignments of this region with other members of the SLC5 gene family in the horse which
show structural similarity; the amino acid affected by the mutation is conserved in all of these members.
doi:10.1371/journal.pgen.1002133.g003
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uncertainty regarding tissue distribution and function of SLC5A3, it
cannot be assumed that the profound anemia and severe loss of
circulating B-lymphocytes in FIS is directly due to a functional
change in SLC5A3 expression or function; formal proof that this is
the case will entail functional studies. Whilst there is no doubt that
the mutation in this gene is predictive of carrier or disease status, the
mechanism by which this amino acid change could lead to the two
described pathologies is speculative. It is, of course possible that the
mutation site is close to another, as yet unidentified, mutation that is
ultimately responsible for the severe hematological and immuno-
logical changes in homozygotes. However, all coding sequence
within the critical region has been fully investigated and this is the
only variant that segregates with the disease. We hypothesize that
the phenotype seen in FIS-affected foals is either a result of partial
loss or subtle alteration in SLC5A3 activity that has deleterious
effects on B-lymphocyte and erythroid development but cannot
discount the involvement of other genetic variants in the critical
region. Whichever is the case, further analysis of FIS is justified as
this genetically determined combination of immune phenotypes has
not previously been reported in any other species.
Materials and Methods
Ethics Statement
Procedures were limited to the collection of blood by jugular
venipuncture or hairs pulled from the mane or tail. Blood samples
were taken as veterinary diagnostic procedures as all study animals
were equine patients presenting with clinical signs suggestive of
FIS or were healthy related or unrelated animals that were blood
tested for anemia and/or B-lymphocyte deficiency.
Study Population and Diagnostic Procedures
Many of the Fell and Dales ponies used in this study have been
described previously [6,7]. Study animals were all equine patients
presenting with clinical signs suggestive of FIS or were healthy
related or unrelated Fell or Dales ponies that were blood tested for
anemiaand/orB-lymphocytedeficiency.SeveralFISfoalspresented
subsequent to euthanasia. Pedigree information was available for
many of the Fell ponies (Figure S1), and these samples (n=41) were
used in the linkage and homozygosity mapping analysis. An
additional ten samples were added to these for the association study;
these were isolated samples for which no pedigree information and/
or samples from immediate family were available. Any adult Fell
pony was eligible as a control for the association study.
FIS diagnosis was based on breed, age of animal (4–8 weeks at
presentation), and profound anemia with no other predisposing
cause, and was confirmed on pathology. Specifically, this indicated
severely reduced numbers (or absence) of germinal centers in
spleen and regional lymph nodes. B-lymphocyte deficiency was
also used for FIS diagnosis. Many accompanying clinical signs
were also reported, primarily related to opportunistic infections,
but these were not considered diagnostic alone.
Samples
Blood samples were collected in EDTA collection tubes from all
of the Fell pony individuals indicatedin Figure S1, and from a Dales
foal and it’s parents [6]. Genomic DNA was isolated from the
samples using a Nucleon
TM BACC Genomic DNA Extraction Kit.
Microsatellite Markers
A panel of 228 markers, distributed as evenly as possible over
the equine genome and described in Table S1, was used. Two
further markers, TKY1155 and TKY2012, which were located in
the implicated region, were subsequently genotyped.
The genome scan was performed in multiplexes of three markers.
Four PCR reactions, each utilisingad i f f e r e n tf l u o r e s c e n td y e ,w e r e
pooled together post-PCR to form a panel of 12 markers for analysis.
An 18 bp tail (59-TGACCGGCAGCAAAATTG-39) was added to
the 59 end of the forward primer and a complementary fluorescent
labelling primer was included in the PCR reaction as a means of
making the reactions more efficient and to reduce costs [27].
Amplification was performed in 6 ml volumes, using 2.5 pmol of
reverse, 1 pmol of tailed-forward, 5 pmol of the labelled universal
p r i m e r( e i t h e r6 - F A M ,V I C ,N E D ,o rP E T ) ,2 0n gg e n o m i cD N A ,
0.75 unit AmpliTaq Gold (Applied Biosystems), 16GeneAmp PCR
buffer II (Applied Biosystems), 1.5 mM MgCl2, and 200 mMe a c h
dNTP. After denaturation at 94uC for 10 min, a 30-cycle PCR of
94uCf o r1m i n ,5 5 uC for 1 min, and 72uC for 1 min, followed by 8
cycles of 94uCf o r1m i n ,5 0 uCf o r1m i n ,a n d7 2 uCf o r1m i nw a s
performed, followed by a final extension at 72uC for 30 min.
Genotyping analysis was performed on an ABI3100 (Applied
Biosystems) according to the manufacturer’s instructions. Genotyping
data wasanalysed with GeneMapper version 4.0 (Applied Biosystems);
alleles were assigned to pre-defined bins and automatically given an
appropriate integer value. Mendelian inheritance was checked.
Linkage and Homozygosity Mapping
We used 41 ponies (14 FIS-affected, 17 obligate carriers, 10
adults of unknown carrier status) for which pedigree information
and DNA was available, in the linkage analysis (Figure S1).
A parametric linkage analysis was carried out using SUPER-
LINK v.1.5 [28] assuming an autosomal recessive mode of
inheritance. The disease allele frequency was estimated at 0.1,
with 100% penetrance.
Pearson’s chi
2 test of independence was used to identify markers
where homozygosity varied significantly between the cases and
controls. An A62 (where A= number of alleles at a given locus)
contingency table with A-1 degrees of freedom was used. Expected
and observed heterozygosity values were computed for cases and
controls for all markers exhibiting a positive LOD score, using
ARLEQUIN [29]. Statistical significance was assessed by calculat-
ing the one-tailed probability of the chi squared distribution.
Genome-Wide Association Mapping
SNP genotyping on 51 genomic DNA samples was performed
using standard manufacturer’s protocols by Cambridge Genomic
Services (University of Cambridge, UK). The Illumina Equi-
neSNP50 Infinium BeadChip, which contains 54,602 validated
SNPs, was used; information on this array is available at http://
www.illumina.com/documents/products/datasheets/datasheet_
equine_snp50.pdf. Quality control and genotype calling were
performed using GenomeStudio v.2009.2 (Illumina Inc.). Samples
with a call rate ,95% were discarded (n=2). We performed a basic
case-control association analysis on the remaining 49 samples (18
affected and 31 controls). Analysis was performed with the software
packagePLINK[30].SNPswithlowminorallelefrequency(,0.02)
or genotyping rate (,90%) were excluded; this left 42,536 SNPs for
analysis.Thepresenceofpopulationstratificationwasassessedusing
multi-dimensional scaling (Figure S2) and quantile-quantile plots
were drawn to confirm that there was no over-inflation of the test
statistics (Figure S3).
Fine Mapping
A total of 62 polymorphic SNPs were studied in 13 affected
individuals. A subset of these helped to delineate recombination
breakpoints and these are identified in Figure 2. Information
Identifying the Mutation in FIS
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ftp/distribution/horse_snp_release/v2/equcab2.0_chr26_snps.xls.
PCR amplification of the target sequence containing each
informative SNP was performed in 12 ml volumes containing
20 ng genomic DNA, 0.75 unit AmpliTaq Gold, 16 GeneAmp
PCR buffer II, 1.5 mM MgCl2, 200 mM each dNTP, 10 pmol of
reverse and of tailed-forward primer. A PCR program of 94uC for
10 min, followed by 30 cycles of 94uC for 1 min, 58uC for 1 min,
and 72uC for 2 min, and then an extension of 72uC for 10 min
was used. The PCR products were purified (MultiScreen PCR96
filter plates; Millipore) before sequencing in a 6 ml volume using
0.5 mlo f5 6 BigDye Terminator v3.1 (Applied Biosystems), 5–
20 ng PCR template, 1 mlo f1 6 BigDye sequencing buffer and
3.2 pmol universal sequencing primer (Sigma-Aldrich). Templates
.500 bp were also sequenced in the reverse direction. Sequencing
was performed using cycle sequencing: 96uC for 0.5 min, 44 cycles
of 92uC for 4 s, 58uC for 4 s and 72uC for 1.5 min. Purification
was performed by isopropanol precipitation followed by sequenc-
ing on an ABI3100 according to the manufacturer’s instructions.
Sequences were viewed using STADEN [31].
Re-Sequencing of Candidate Region
This was performed at the Centre for Genomic Research
(University of Liverpool, UK). A region of 3 Mb (ECA26:
28,942,655 – 31,942,655 Mb) was selected for re-sequencing which
encompassed the critical region. Custom tiling 385 k NimbleGen
Sequence Capturearrays (http://www.454.com/products-solutions/
experimental-design-options/nimblegen-sequence-capture.asp)
which covered 92.9% of the target were designed from the horse
reference sequence using standard repeat-masking algorithms. Five
individualswereselectedforre-sequencingconsistingofoneaffected
pony (A13 in Figure 2), its parents, one obligate carrier selected for
maximal homozygosity over the region and one individual
apparently homozygous wild-type.
Sequencing was performed using GS FLX Titanium Series
chemistry and assembled using Roche Newbler software v2.0.00.
Anaverage34-foldread depthwasobtained.Sequencefromeachof
the five sequenced animals was aligned to the EquCab2 reference
sequence using the Artemis Comparison Tool (ACT) [32] to
identify possible rearrangements or insertion/deletions (Figure S4).
Identifying Candidate Mutations for FIS
MySQL (Oracle Corporation) was used to interrogate the data.
The critical region was narrowed using heterozygous variants in the
affected foal and Sanger sequencing subsequently verified these.
The narrowed critical region was then interrogated for variants that
segregated as expected for a recessive mutation; putative causal
variants were confirmed or disproved using Sanger sequencing.
Supporting Information
Figure S1 The Fell pony pedigrees used for linkage analysis.
Affected (FIS) individuals are shown shaded in black and obligate
carriers are indicated with a dot. Individuals that are neither
affected or obligate carriers are shown un-shaded. Individuals also
coloured yellow were genotyped and used for linkage and
homozygosity mapping. Double lines indicate consanguinity.
(TIF)
Figure S2 Multidimensional scaling plot of first two compo-
nents. Multidimensional scaling analysis illustrating the first two
components of Identity-By-State similarity for all FIS-affected (red
squares) and controls (blue circles) used in the genome-wide
association analysis. A permutation test (10,000 permutations) for
between-group IBS differences showed that there was no
significant difference between the affected and controls (P=0.553).
(TIF)
Figure S3 Observed versus expected log10(P). A Q-Q plot
showing the distribution of expected versus observed –log10P for
the basic association test with no adjustment. The pink diagonal
shows the values expected under the null hypothesis. The observed
–log10P values match the expected values along the major portion
of the graph and deviate towards the end illustrating the small
number of true associations. The plot indicates minimal
population stratification and therefore no corrections were
subsequently made to the data.
(TIF)
Figure S4 Alignment of re-sequenced region from FIS pony to
the EquCab2 reference sequence. Sequence from the FIS-affected
pony was aligned to the EquCab2 reference sequence using the
Artemis Comparison Tool (ACT) [32] to identify possible
rearrangements, duplications or insertion/deletions. Red indicates
alignment of the sequence. White regions indicate missing
sequence caused either by missing probe design, or small tandem
repeats which result in reads stacking on top of each other and
causing a break in the contig. Blue lines indicate inverted repeats
scattered throughout the sequence. Black lines represent blocks of
synteny used for sequence comparison and do not represent
sequence variation. These alignments provide no evidence for
significant rearrangement, duplication or insertion/deletion within
the sequences; there is an excellent match between the FIS pony
and the reference sequence.
(TIF)
Table S1 Panel of 228 microsatellite markers used in linkage
and homozygosity mapping.
(DOC)
Table S2 Linkage analysis and homozygosity mapping of FIS
using a genome-wide microsatellite set.
(DOC)
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